author-photo

Rogier M. Reijmers

Leiden University Medical Center

3

Papers

36

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

An HLA-A*11:01-Binding Neoantigen from Mutated NPM1 as Target for TCR Gene Therapy in AML.

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (0)
Simultaneous deletion of endogenous TCRαβ for TCR gene therapy creates an improved and safe cellular therapeutic. Creating an improved T-cell therapeutic.

2019 Molecular Therapy
Show All
- Source
- Cite
- Save
Citations (15)
Framework engineering to produce dominant T cell receptors with enhanced antigen-specific function

2019 Nature Communications
Show All
- Source
- Cite
- Save
Citations (21)